Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

New York, Jan 9, 2026, 13:38 EST — Regular session

  • Bitcoin slid roughly 0.5% to about $90,700; ether and XRP edged lower too
  • Coinbase fell about 2% while Strategy slid nearly 5% in U.S. trade; miners finished mixed
  • Traders are eyeing U.S. inflation data due next week, along with whether ETF flows continue to drain

Bitcoin eased back Friday and was last hovering around $90,700, while crypto-linked stocks such as Coinbase and Strategy slid in the U.S. regular session. Ether fell about 1% and XRP dropped nearly 2%, leaving the broader complex on the back foot after its early-year bounce.

The dip carried weight with rates back in the driver’s seat for risk assets, and the latest U.S. jobs report didn’t do much to end the debate. Nonfarm payrolls rose 50,000 in December, short of economists’ 60,000 forecast in a Reuters poll, while the unemployment rate eased to 4.4%. “The good news there is that it gives the Fed the ability to cut rates,” Adam Sarhan, chief executive at 50 Park Investments, said in remarks after the data. (Reuters)

Interest-rate futures kept signaling the Federal Reserve is likely to stand pat later this month, even after the softer print. Fed funds futures are pricing a 95% chance the Fed holds rates at its Jan. 27-28 meeting, according to CME FedWatch, Reuters reported. In currencies, the dollar firmed, and a closely watched U.S. Supreme Court tariff ruling won’t be issued on Friday, though it could still come next week. (Reuters)

ETF flows kept weighing on the market. Investors withdrew $486.1 million from U.S. spot bitcoin ETFs on Jan. 7 and another $398.8 million on Jan. 8, according to Farside Investors data. Spot bitcoin ETFs are exchange-traded funds that hold bitcoin directly, offering exposure without investors owning the tokens themselves. (Farside)

Crypto-linked stocks were mostly lower: Coinbase dropped about 2.4% and Strategy sank about 4.7%. Bitcoin miners were mixed, with Marathon Digital off about 1.9% while Riot Platforms rose about 2.5%. BlackRock’s iShares Bitcoin Trust ETF was little changed.

Bitcoin is still well under its record above $126,000 from early October, with traders quicker to fade rallies when ETF demand isn’t consistent. The retreat has also put the spotlight back on bitcoin’s long-standing tie to broader risk appetite as yields and the dollar strengthen. (Reuters)

Still, the next leg isn’t locked in. Another wave of ETF redemptions would put sentiment at the $90,000 line under pressure, and a hotter-than-expected inflation print could drive yields higher and tighten the screws on risk assets more broadly.

The next obvious catalyst is U.S. consumer price index data for December, due on Jan. 13, ahead of the Fed’s Jan. 27-28 policy meeting. (Bureau of Labor Statistics)

Stock Market Today

  • Silver Storm Mining Valuation Ahead of Vancouver Resource Investment Conference 2026
    January 30, 2026, 3:47 PM EST. Silver Storm Mining (TSXV:SVRS) prepares for the Vancouver Resource Investment Conference 2026 on January 25, with CEO Gregory McKenzie presenting. The stock's recent surge includes a 174.51% return over 90 days and strong 1-year total shareholder returns, highlighting significant momentum. Trading at CA$0.70 per share with a price-to-book (P/B) ratio of 10.4x, it sits above the Canadian Metals and Mining industry average of 3.9x but below the 13.4x peer group average. The P/B ratio reflects investor optimism despite zero revenue and a CA$15.20 million net loss. Analysts' target price of CA$0.55 suggests the current valuation may be full. Investors should weigh the premium pricing against inherent risks in this early-stage mining company.
Eaton stock rises today as Barclays trims target; CPI and earnings loom
Previous Story

Eaton stock rises today as Barclays trims target; CPI and earnings loom

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny
Next Story

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Go toTop